Schrödinger, Inc. (SDGR) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $11.91. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SDGR = $155.32 (+1204.1% from the current price, the stock appears undervalued). Analyst consensus target is SDGR = $18 (+51.1% upside).
Valuation: SDGR trades at a trailing Price-to-Earnings (P/E) of -8.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.27.
Financials: revenue is $256M, +12.9%/yr average growth. Net income is $103M (loss), growing at -129.1%/yr. Net profit margin is -40.4% (negative). Gross margin is 55.7% (-0.1 pp trend).
Balance sheet: total debt is $109M against $364M equity (Debt-to-Equity (D/E) ratio 0.3, conservative). Current ratio is 2.75 (strong liquidity). Debt-to-assets is 15%. Total assets: $726M.
Analyst outlook: 8 / 12 analysts rate SDGR as buy (67%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 25/100 (Fail), Health 100/100 (Pass), Moat 60/100 (Partial), Future 73/100 (Pass), Income 10/100 (Fail).
